140 related articles for article (PubMed ID: 32886204)
1. Hepatobiliary phase enhancement of liver metastases on gadoxetic acid MRI: assessment of frequency and patterns.
Bhayana R; Baliyan V; Kordbacheh H; Kambadakone A
Eur Radiol; 2021 Mar; 31(3):1359-1366. PubMed ID: 32886204
[TBL] [Abstract][Full Text] [Related]
2. The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine tumor.
Hayoz R; Vietti-Violi N; Duran R; Knebel JF; Ledoux JB; Dromain C
Eur Radiol; 2020 Dec; 30(12):6593-6602. PubMed ID: 32601948
[TBL] [Abstract][Full Text] [Related]
3. Hepatobiliary contrast uptake patterns on gadoxetic acid-enhanced MRI in liver metastases from pancreatic ductal adenocarcinoma: can it predict prognosis?
Noda Y; Tochigi T; Baliyan V; Kordbacheh H; Kambadakone A
Eur Radiol; 2021 Jan; 31(1):276-282. PubMed ID: 32783131
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetic acid-enhanced 3.0T MRI for the evaluation of hepatic metastasis from colorectal cancer: metastasis is not always seen as a "defect" on the hepatobiliary phase.
Kim A; Lee CH; Kim BH; Lee J; Choi JW; Park YS; Kim KA; Park CM
Eur J Radiol; 2012 Dec; 81(12):3998-4004. PubMed ID: 22921889
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of morphological enhancement patterns in the hepatobiliary phase of gadoxetic acid-enhanced MRI to distinguish focal nodular hyperplasia from hepatocellular adenoma.
Bilreiro C; Soler JC; Ayuso JR; Caseiro-Alves F; Ayuso C
Radiol Med; 2021 Nov; 126(11):1379-1387. PubMed ID: 34287759
[TBL] [Abstract][Full Text] [Related]
6. Patterns of enhancement in the hepatobiliary phase of gadoxetic acid-enhanced MRI.
Hui CL; Mautone M
Br J Radiol; 2020 Aug; 93(1112):20190989. PubMed ID: 32462892
[TBL] [Abstract][Full Text] [Related]
7. Abbreviated Gadoxetic Acid-Enhanced MRI for the Detection of Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Adenocarcinoma.
Yamaguchi T; Sofue K; Ueshima E; Ueno Y; Tsujita Y; Yabe S; Shirakawa S; Toyama H; Hori M; Fukumoto T; Murakami T
J Magn Reson Imaging; 2022 Sep; 56(3):725-736. PubMed ID: 35005813
[TBL] [Abstract][Full Text] [Related]
8. Imaging features of fibrolamellar hepatocellular carcinoma in gadoxetic acid-enhanced MRI.
Palm V; Sheng R; Mayer P; Weiss KH; Springfeld C; Mehrabi A; Longerich T; Berger AK; Kauczor HU; Weber TF
Cancer Imaging; 2018 Mar; 18(1):9. PubMed ID: 29490696
[TBL] [Abstract][Full Text] [Related]
9. Paradoxical uptake of Gd-EOB-DTPA on the hepatobiliary phase in the evaluation of hepatic metastasis from breast cancer: is the "target sign" a common finding?
Ha S; Lee CH; Kim BH; Park YS; Lee J; Choi JW; Kim KA; Park CM
Magn Reson Imaging; 2012 Oct; 30(8):1083-90. PubMed ID: 22578929
[TBL] [Abstract][Full Text] [Related]
10. Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine.
Khouri Chalouhi C; Vernuccio F; Rini F; Duca P; Tuscano B; Brancatelli G; Vanzulli A
Eur Radiol; 2019 Jun; 29(6):3090-3099. PubMed ID: 30547205
[TBL] [Abstract][Full Text] [Related]
11. Focal fat deposition at liver MRI with gadobenate dimeglumine and gadoxetic acid: Quantitative and qualitative analysis.
Yeom SK; Byun JH; Kim HJ; Park SH; Kim N; Shin YM; Kim PN
Magn Reson Imaging; 2013 Jul; 31(6):911-7. PubMed ID: 23598063
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of OATP1B3 in colorectal cancer liver metastases and its clinical implication on gadoxetic acid-enhanced MRI.
Park SH; Kim H; Kim EK; Kim H; Choi DK; Chung YE; Kim MJ; Choi JY
Oncotarget; 2017 Sep; 8(41):71012-71023. PubMed ID: 29050339
[TBL] [Abstract][Full Text] [Related]
13. "Nondefect" of arterial enhancing rim on hepatobiliary phase in 3.0-T gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced liver magnetic resonance imaging: distinguishing hepatic abscess from metastasis.
Choi SH; Lee CH; Kim BH; Lee J; Choi JW; Park YS; Kim KA; Park CM
J Comput Assist Tomogr; 2013; 37(6):849-55. PubMed ID: 24270105
[TBL] [Abstract][Full Text] [Related]
14. Rim enhancement on hepatobiliary phase of pre-treatment 3.0 T MRI: A potential marker for early chemotherapy response in colorectal liver metastases treated with XELOX.
Wang X; Wang Y; Zhang Z; Zhou M; Zhou X; Zhao H; Xing J; Zhou Y
Eur J Radiol; 2021 Oct; 143():109887. PubMed ID: 34454297
[TBL] [Abstract][Full Text] [Related]
15. Hepatobiliary phase imaging in cirrhotic patients using compressed sensing and controlled aliasing in parallel imaging results in higher acceleration.
Yoon S; Shim YS; Park SH; Sung J; Nickel MD; Kim YJ; Lee HY; Kim HJ
Eur Radiol; 2024 Apr; 34(4):2233-2243. PubMed ID: 37731096
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.
Kang Y; Lee JM; Kim SH; Han JK; Choi BI
Radiology; 2012 Sep; 264(3):751-60. PubMed ID: 22798225
[TBL] [Abstract][Full Text] [Related]
17. The target sign in colorectal liver metastases: an atypical Gd-EOB-DTPA "uptake" on the hepatobiliary phase of MR imaging.
Granata V; Catalano O; Fusco R; Tatangelo F; Rega D; Nasti G; Avallone A; Piccirillo M; Izzo F; Petrillo A
Abdom Imaging; 2015 Oct; 40(7):2364-71. PubMed ID: 26105523
[TBL] [Abstract][Full Text] [Related]
18. Value of gadoxetic acid-enhanced MRI and diffusion-weighted imaging in the differentiation of hypervascular hyperplastic nodule from small (<3 cm) hypervascular hepatocellular carcinoma in patients with alcoholic liver cirrhosis: A retrospective case-control study.
Kim SS; Kim SH; Song KD; Choi SY; Heo NH
J Magn Reson Imaging; 2020 Jan; 51(1):70-80. PubMed ID: 31062483
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
Kim R; Lee JM; Shin CI; Lee ES; Yoon JH; Joo I; Kim SH; Hwang I; Han JK; Choi BI
Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
[TBL] [Abstract][Full Text] [Related]
20. Hypovascular hepatic nodules at gadoxetic acid-enhanced MRI: whole-lesion hepatobiliary phase histogram metrics for prediction of progression to arterial-enhancing hepatocellular carcinoma.
Rosenkrantz AB; Pinnamaneni N; Kierans AS; Ream JM
Abdom Radiol (NY); 2016 Jan; 41(1):63-70. PubMed ID: 26830613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
